mSOAR and Early Mortality in Acute Stroke

Condition(s) studied

Investigational drug(s) / intervention(s)

No Intervention (Observational Study): Participants will receive standard of care only. No study-specific intervention is applied.

Study summary

This observational study aims to evaluate the predictive accuracy of the Modified SOAR score for early mortality in patients with acute stroke. Adult patients presenting with acute stroke at Sohag University Hospitals will be included. Data on clinical presentation, medical history, and relevant laboratory investigations will be collected. The study will follow patients during their hospital stay to determine outcomes related to early mortality. The findings will help improve early risk stratification and management of acute stroke patients.

Eligibility

Primary outcome measure(s)

• Early Mortality — 7days
  Assessment of early mortality in patients with acute stroke during the follow-up period.
• Early mortality — 7 days
  Assessment of early mortality in patients with acute stroke during the first 7 days of hospital admission. Patients will be monitored from hospital admission until 7 days or until death, whichever occurs first. The Modified SOAR score will be recorded for each patient at admission to evaluate its predictive accuracy for early mortality within this period.

Trial sites (1)

More Sohag University trials in Egypt

Other trials for the same condition